BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31996488)

  • 1. Osborn Wave Is Related to Ventricular Fibrillation and Tachycardia in Hypothermic Patients.
    Okada N; Matsuyama T; Morita S; Ehara N; Miyamae N; Okada Y; Jo T; Sumida Y; Watanabe M; Nozawa M; Tsuruoka A; Fujimoto Y; Okumura Y; Hamanaka K; Kitamura T; Nishiyama K; Ohta B
    Circ J; 2020 Feb; 84(3):445-455. PubMed ID: 31996488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tpeak-Tend interval during therapeutic hypothermia can predict upcoming ventricular fibrillation in subjects with aborted arrhythmic sudden cardiac death: 3-years follow-up results.
    Yoon N; Hong S; Glass A; Kim SS; Kim MC; Cho JY; Lee KH; Sim DS; Yoon HJ; Kim KH; Hong YJ; Park HW; Kim JH; Ahn Y; Jeong M; Park JC; Cho JG
    Europace; 2017 Dec; 19(suppl_4):iv17-iv24. PubMed ID: 29220423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study.
    Shizuta S; Ando K; Nobuyoshi M; Ikeda T; Yoshino H; Hiramatsu S; Kazatani Y; Yamashiro K; Okajima K; Kajiya T; Kobayashi Y; Kato T; Fujii S; Mitsudo K; Inoue K; Ito H; Haruna Y; Doi T; Nishio Y; Ozasa N; Nishiyama K; Kita T; Morimoto T; Kimura T;
    Clin Res Cardiol; 2012 Feb; 101(2):89-99. PubMed ID: 21960418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic parameters effectively predict ventricular tachycardia/fibrillation in acute phase and abnormal cardiac function in chronic phase of ST-segment elevation myocardial infarction.
    Yu Z; Chen Z; Wu Y; Chen R; Li M; Chen X; Qin S; Liang Y; Su Y; Ge J
    J Cardiovasc Electrophysiol; 2018 May; 29(5):756-766. PubMed ID: 29399929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone.
    Gurabi Z; Koncz I; Patocskai B; Nesterenko VV; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):134-42. PubMed ID: 24429494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interlead heterogeneity of R- and T-wave morphology in standard 12-lead ECGs predicts sustained ventricular tachycardia/fibrillation and arrhythmic death in patients with cardiomyopathy.
    Tan AY; Nearing BD; Rosenberg M; Nezafat R; Josephson ME; Verrier RL
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1324-1333. PubMed ID: 28675579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal method of measuring the T-peak to T-end interval for risk stratification in primary prevention.
    Rosenthal TM; Masvidal D; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Rogers PA; Xue JQ; Morin DP
    Europace; 2018 Apr; 20(4):698-705. PubMed ID: 28339886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of functional changes in ventricular late potentials for risk assessment of ventricular tachycardias after myocardial infarct].
    Steinbigler P; Haberl R; Jilge G; Knez A; Dorwarth U; Müller D; Hoffmann E; Steinbeck G
    Z Kardiol; 1998 Jun; 87(6):459-70. PubMed ID: 9691416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The incidence and significance of late potentials in patients with aborted sudden death].
    Sanjuán R; Morell S; Samper J; García Civera R; Ruiz R; Muñoz J; Botella S; López Merino V
    Rev Esp Cardiol; 1994 Mar; 47(3):157-64. PubMed ID: 8184166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification for complex ventricular arrhythmia complicating ST-segment elevation myocardial infarction.
    Podolecki TS; Lenarczyk RK; Kowalczyk JP; Jedrzejczyk-Patej EK; Chodor PK; Mazurek MH; Francuz PJ; Streb WA; Mitrega KA; Kalarus ZF
    Coron Artery Dis; 2018 Dec; 29(8):681-686. PubMed ID: 30234552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory ECG-based T-wave alternans and heart rate turbulence predict high risk of arrhythmic events in patients with old myocardial infarction.
    Maeda S; Nishizaki M; Yamawake N; Ashikaga T; Shimada H; Asano M; Ihara K; Murai T; Suzuki H; Fujii H; Sakurada H; Hiraoka M; Isobe M
    Circ J; 2009 Dec; 73(12):2223-8. PubMed ID: 19838004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of prior myocardial infarction patients prone to malignant ventricular arrhythmias using wavelet transform analysis.
    Yodogawa K; Ohara T; Takayama H; Seino Y; Katoh T; Mizuno K
    Int Heart J; 2011; 52(5):286-9. PubMed ID: 22008437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the World Health Organization Definition: Predicting Autopsy-Defined Sudden Arrhythmic Deaths Among Presumed Sudden Cardiac Deaths in the POST SCD Study.
    Tseng ZH; Salazar JW; Olgin JE; Ursell PC; Kim AS; Bedigian A; Probert J; Hart AP; Moffatt E; Vittinghoff E
    Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007171. PubMed ID: 31248279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LV mechanical dispersion as a predictor of ventricular arrhythmia in patients with advanced systolic heart failure : A pilot study.
    Banasik G; Segiet O; Elwart M; Szulik M; Lenarczyk R; Kalarus Z; Kukulski T
    Herz; 2016 Nov; 41(7):599-604. PubMed ID: 26883898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
    Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
    Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.